What's Going On With TRxADE Health Stock?
Portfolio Pulse from Erica Kollmann
TRxADE Health (NASDAQ:MEDS) shares surged after the company announced the acquisition of Superlatus, Inc., a US-based holding company of food products and distribution capabilities. The deal will see Superlatus shareholders receive 3,839,176 shares of MEDS, representing 19.99% of the total issued and outstanding stock.
June 26, 2023 | 2:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TRxADE Health's acquisition of Superlatus, Inc. has led to a surge in its share price, with the stock trading higher by more than 110%.
The acquisition of Superlatus, Inc. by TRxADE Health is expected to unlock significant value and synergies, making the combined entities a significant player in the competitive food and snack marketplace. This has led to a surge in MEDS share price, with the stock trading higher by more than 110%.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100